ARGENTINA APPROVES APPLIED BIOSYSTEMS' VIROSEQ KIT.Applied Biosystems (NYSE NYSE See: New York Stock Exchange : PEB PEB Physical Evaluation Board PEB Presidential Emergency Board PEB Post Exposure Bake PEB Professional Engineers Board (Singapore) PEB Pre-Engineered Building PEB Personal Electronic Ballot PEB Performance Evaluation Board ), Foster City, Calif., a PE Corporation business, has announced that the Argentine Ministry of Health has approved the sale of the ViroSeq(tm) HIV-1 Genotyping System Version 2 for diagnostic purposes. It is the first HIV-1 genotyping system to receive such approval in Argentina. This authorization grants to BioSystems SA -- Applied Biosystems distributor in Argentina -- the right to market the ViroSeq system to reference laboratories for the management of HIV-1 therapies Argentina is the first country to authorize the system for clinical use ; similar approval by other South American countries is expected soon. The Ministry of Health granted its approval after subjecting the ViroSeq system to rigorous validation tests, conducted by Drs. Jorge Benetucci and Juan Carlos Garberi at the Foundation for the Study of Immunodeficiency. The Foundation is an affiliate of Hospital General de Infecciosos F. J. Muniz , a reference hospital in Argentina dedicated to infectious diseases. Clinicians there will use the ViroSeq system to conduct in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. studies of the HIV-1 virus. According to Stan Weinstein, senior marketing manager for molecular diagnostics, "This action by the Ministry of Health in Buenos Aires opens up an important market for us. We have always believed that the ViroSeq system is a valuable tool in the war against HIV-1, and we are extremely pleased that the Argentine government has approved our application." A pioneer and market leader in the development and manufacture of automated systems for life science research, Applied Biosystems is also becoming a market leader in the emerging field of molecular diagnostics. It hopes eventually to establish its HIV-1 genotyping system as an important diagnostic tool in clinical laboratories around the world. The ViroSeq system is currently marketed in the US as a Research-Use-Only ( RUO RUO Research Use Only RUO Reference Unbundling Offer RUO Run Ultima Online (emulator program) RUO Resident Unit Officer ) product. Applied Biosystems is diligently working for FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. authorization to market the ViroSeq system in the US for In Vitro Diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. (IVD (Interactive VideoDisc) See interactive video. ) use About PE Corporation PE Corporation comprises two operating groups. The PE Biosystems Group, now conducting business under the Applied Biosystems name, develops and market s instrument-based systems, reagents, software and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, Calif. and reported sales of $1.4 billion during fiscal 2000. The Celera Genomics Group (NYSE: CRA See Community Reinvestment Act. ), headquartered in Rockville, Md., intends to become the definitive source of genomic and related medical information. Visit http://www.pecorporation.com or call 800.762.6923. For more information, call 800.345.5224 or 650.638.6443 or visit http://www.appliedbiosystems.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion